| Literature DB >> 27726050 |
Marie Hully1, Juliette Ropars2,3, Laurence Hubert4,5, Nathalie Boddaert4,6,7, Marlene Rio8, Mathieu Bernardelli9, Isabelle Desguerre1,4, Valerie Cormier-Daire4,8, Arnold Munnich4,8, Pascale de Lonlay4,10, Louise Reilly4,11,12, Claude Besmond4,5, Nadia Bahi-Buisson13,14,15.
Abstract
Mutations in ATP1A3 are involved in a large spectrum of neurological disorders, including rapid onset dystonia parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and cerebellar ataxia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS), with recent descriptions of overlapping phenotypes. In AHC, a few familial cases of autosomal dominant inheritance have been reported, along with cases of de novo sporadic mutations. In contrast, autosomal dominant inheritance has frequently been associated with RDP and CAPOS. Here, we report on two unrelated sets of full siblings with ATP1A3 mutations, (c.2116G>A) p. Gly706Arg in the first family, and (c.2266C>T) p. Arg756Cys in the second family, presenting with familial recurrence of the disease. Both families displayed parental germline mosaicism. In the first family, the brother and sister presented with severe intellectual deficiency, early onset pharmacoresistant epilepsy, ataxia, and autistic features. In the second family, both sisters demonstrated severe encephalopathy with ataxia and dystonia following a regression episode during a febrile episode during infancy. To our knowledge, mosaicism has not previously been reported in ATP1A3-related disorders. This report, therefore, provides evidence that germline mosaicism for ATP1A3 mutations is a likely explanation for familial recurrence and should be considered during recurrence risk counseling for families of children with ATP1A3-related disorders.Entities:
Keywords: ATP1A3; Alternating hemiplegia of childhood (AHC); Genetic counseling; Mosaicism; Rapid onset dystonia parkinsonism (RDP)
Mesh:
Substances:
Year: 2016 PMID: 27726050 DOI: 10.1007/s10048-016-0498-9
Source DB: PubMed Journal: Neurogenetics ISSN: 1364-6745 Impact factor: 2.660